What is the share price of Healthcare Global Enterprises Ltd (HCG) today?
The share price of HCG as on 23rd May 2025 is ₹594.65. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Healthcare Global Enterprises Ltd (HCG) share?
The past returns of Healthcare Global Enterprises Ltd (HCG) share are- Past 1 week: -0.52%
- Past 1 month: 3.99%
- Past 3 months: 18.99%
- Past 6 months: 25.71%
- Past 1 year: 67.14%
- Past 3 years: 114.06%
- Past 5 years: 497.64%
What are the peers or stocks similar to Healthcare Global Enterprises Ltd (HCG)?
The peers or stocks similar to Healthcare Global Enterprises Ltd (HCG) include:What is the market cap of Healthcare Global Enterprises Ltd (HCG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Healthcare Global Enterprises Ltd (HCG) is ₹8365.62 Cr as of 23rd May 2025.What is the 52 week high and low of Healthcare Global Enterprises Ltd (HCG) share?
The 52-week high of Healthcare Global Enterprises Ltd (HCG) is ₹639 and the 52-week low is ₹330.65.What is the PE and PB ratio of Healthcare Global Enterprises Ltd (HCG) stock?
The P/E (price-to-earnings) ratio of Healthcare Global Enterprises Ltd (HCG) is 173.81. The P/B (price-to-book) ratio is 9.67.Which sector does Healthcare Global Enterprises Ltd (HCG) belong to?
Healthcare Global Enterprises Ltd (HCG) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Healthcare Global Enterprises Ltd (HCG) shares?
You can directly buy Healthcare Global Enterprises Ltd (HCG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Healthcare Global Enterprises Ltd
HCG Share Price
594.650.90% (-5.40)
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HCG Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HCG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 143.47 | 9.67 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.78 | 6.46 | 0.86% |
HCG Analyst Ratings & Forecast
Detailed Forecast 75%
Analysts have suggested that investors can buy this stock
from 8 analysts
Price Upside
Earnings Growth
Rev. Growth
HCG Company Profile
Healthcare Global Enterprises Limited is a specialty healthcare provider. The Company is focused on cancer and fertility.
Investor Presentation
View olderHCG Similar Stocks (Peers)
Compare with peersMAXHEALTH
PE Ratio
103.75
1Y Return
42.98%
Buy Reco %
75.00
APOLLOHOSP
PE Ratio
111.28
1Y Return
18.33%
Buy Reco %
86.21
FORTIS
PE Ratio
70.58
1Y Return
53.33%
Buy Reco %
100.00
PE Ratio
44.33
1Y Return
37.39%
Buy Reco %
66.67
MEDANTA
PE Ratio
66.09
1Y Return
1.46%
Buy Reco %
71.43
HCG Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
HCG Stock Summary · March 2025
The company reported a record quarterly revenue of INR 559 crores, reflecting a robust 19% year-on-year growth, driven by increased patient volumes and operational efficiencies. While challenges in international patient revenue due to geopolitical issues persist, management remains optimistic about domestic growth, particularly in the expanding oncology market, where emerging centers are performing exceptionally well. A strategic focus on precision medicine and partnerships with technology firms aims to enhance treatment outcomes, aligning with the company's commitment to clinical excellence. Despite a leadership transition, the emphasis on long-term planning and substantial capital expenditure for new centers underscores a balanced approach to growth, while efforts to improve profitability at the South Mumbai center signal a proactive recovery strategy. Overall, the outlook remains positive, supported by a strong operational framework and a commitment to enhancing shareholder value.
Key Points on Hcg Stock
HCG Stock Growth Drivers
7Strong Financial Performance
Healthcare Global Enterprises Limited (HCG) reported its highest quarterly revenue of INR 559 crores for
Commitment to Precision Medicine
HCG emphasizes its commitment to developing precision medicine tailored to Indian patients, leveraging technology and
HCG Stock Challenges
4Declining EBITDA Margins
The company has experienced a decrease in EBITDA margins, dropping from 18.5% in Q2 to
Operational Losses in Emerging Centers
The company is facing operational losses in its emerging centers, particularly in South Mumbai, where
HCG Forecasts
HCG Forecast
Price
Revenue
Earnings
HCG Share Price Forecast
2025
Current
₹594.65
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹594.65
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HCG Company Revenue Forecast
2024
Current
₹1.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2024
Current
₹1.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
HCG Stock EPS (Earnings Per Share) Forecast
2024
Current
₹3.46
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹3.46
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HCG
Income
Balance Sheet
Cash Flow
Annual Normal View
HCG Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 588.16 | 709.78 | 861.91 | 986.09 | 1,102.61 | 1,036.17 | 1,560.36 | 1,707.63 | 1,933.35 | 2,166.81 | ||||||||||
Raw Materials | 149.13 | 175.92 | 196.64 | 221.49 | 236.35 | 238.17 | 360.98 | 432.38 | 479.37 | 1,758.77 | ||||||||||
| Power & Fuel Cost | 14.35 | 16.42 | 22.89 | 28.82 | 33.26 | 31.75 | 34.54 | 36.89 | 39.35 | |||||||||||
| Employee Cost | 100.53 | 121.93 | 157.71 | 184.52 | 208.03 | 195.94 | 233.65 | 275.12 | 308.24 | |||||||||||
| Selling & Administrative Expenses | 64.50 | 83.00 | 285.43 | 362.38 | 367.58 | 333.50 | 430.81 | 526.94 | 609.42 | |||||||||||
| Operating & Other expenses | 176.97 | 197.85 | 58.25 | 67.25 | 90.56 | 187.09 | 156.57 | 124.46 | 146.16 | |||||||||||
EBITDA | 82.68 | 114.66 | 140.99 | 121.63 | 166.83 | 49.72 | 343.81 | 311.84 | 350.81 | 408.04 | ||||||||||
| Depreciation/Amortization | 44.08 | 56.83 | 71.46 | 85.09 | 148.45 | 159.22 | 158.28 | 163.47 | 174.36 | 199.25 | ||||||||||
| PBIT | 38.60 | 57.83 | 69.53 | 36.54 | 18.38 | -109.50 | 185.53 | 148.37 | 176.45 | 208.79 | ||||||||||
| Interest & Other Items | 38.33 | 23.00 | 42.35 | 69.91 | 137.65 | 119.17 | 97.77 | 103.50 | 108.74 | 137.23 | ||||||||||
| PBT | 0.27 | 34.83 | 27.18 | -33.37 | -119.27 | -228.67 | 87.76 | 44.87 | 67.71 | 71.56 | ||||||||||
| Taxes & Other Items | 1.73 | 12.67 | 6.65 | -8.58 | -12.57 | -35.20 | 34.04 | 15.53 | 19.58 | 13.25 | ||||||||||
| Net Income | -1.46 | 22.16 | 20.53 | -24.79 | -106.70 | -193.47 | 53.72 | 29.34 | 48.13 | 58.31 | ||||||||||
| EPS | -0.19 | 2.60 | 2.38 | -2.84 | -12.08 | -18.08 | 4.06 | 2.11 | 3.46 | 4.19 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HCG Company Updates
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2025
Investor Presentation
Feb 16PDF
Nov 9PDF
HCG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Healthcare Global Enterprises Ltd | 173.81 | 9.67 | — |
| Max Healthcare Institute Ltd | 103.75 | 13.28 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 111.28 | 13.66 | 0.23% |
| Fortis Healthcare Ltd | 70.58 | 6.39 | 0.14% |
HCG Stock Price Comparison
Compare HCG with any stock or ETFCompare HCG with any stock or ETF
HCG
HCG Shareholdings
HCG Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HCG Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
HCG Shareholding Pattern
HCG Shareholding History
Foreign Institutions
Mutual Funds Invested in HCG
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Healthcare Global Enterprises Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3532% | Percentage of the fund’s portfolio invested in the stock 1.33% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 27/66 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.2507% | Percentage of the fund’s portfolio invested in the stock 2.00% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 18/64 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.7350% | Percentage of the fund’s portfolio invested in the stock 4.19% | Change in the portfolio weight of the stock over the last 3 months -0.74% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/27 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing HCG stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Healthcare Global Enterprises Ltd
HCG Events
HCG Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HCG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HCG Dividends
Hmm, looks like data is unavailable here. Please come back after some timeHCG Stock News & Opinions
Articles & Videos
Corporate
Healthcare Global Enterprises schedules board meeting
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Spotlight
HCG shares up as KKR set to steer the ship
The agreement, which involves a transaction with CVC, a global private markets manager, will see KKR acquire up to 54% of HCG's equity from CVC Asia V at a price of Rs 445 per share. In accordance with the Securities and Exchange Board of India (SEBI) Takeover Regulations, KKR will also conduct an open offer to purchase additional equity shares from public shareholders. Upon completion of the transaction, KKR's total equity stake in HCG is expected to range between 54% and 77%. Dr. BS Ajaikumar, the founder of HCG, will transition to the role of non-executive chairman, where he will focus on driving clinical, academic, and research and development excellence within the organization. The transaction is expected to close by the third quarter of 2025, subject to customary closing conditions and regulatory approvals. Separately, KKR has initiated an open offer to acquire up to 26% of HCG's expanded voting share capital, offering to purchase 3,70,90,327 equity shares at Rs 504.41 per share, for a total consideration of Rs 1870,87,31,842.07. Founded in 1989, HCG is one of India's largest oncology hospital chains. HCG operates 25 medical care centers across 19 cities with best-in-class infrastructure including 2,500 beds, nearly 100 operating theaters and 40 linear accelerator machines (LINACs). Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Healthcare Global Enterprises consolidated net profit rises 22.46% in the December 2024 quarter
Net profit of Healthcare Global Enterprises rose 22.46% to Rs 6.98 crore in the quarter ended December 2024 as against Rs 5.70 crore during the previous quarter ended December 2023. Sales rose 18.89% to Rs 557.55 crore in the quarter ended December 2024 as against Rs 468.95 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales557.55468.95 19 OPM %15.8516.76 - PBDT53.2255.22 -4 PBT-3.3011.06 PL NP6.985.70 22 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises revises board meeting date
Healthcare Global Enterprises has revised the meeting of the Board of Directors which was scheduled to be held on 13 February 2025. The meeting will now be held on 14 February 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises to hold board meeting
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Healthcare Global Enterprises consolidated net profit rises 32.57% in the September 2024 quarter
Net profit of Healthcare Global Enterprises rose 32.57% to Rs 17.99 crore in the quarter ended September 2024 as against Rs 13.57 crore during the previous quarter ended September 2023. Sales rose 13.69% to Rs 552.47 crore in the quarter ended September 2024 as against Rs 485.96 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales552.47485.96 14 OPM %18.5117.41 - PBDT77.3961.13 27 PBT27.6517.92 54 NP17.9913.57 33 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises to acquire oncology biz of HCG NCHRI Oncology LLP
Healthcare Global Enterprises has executed Business Transfer Agreement on 09 November 2024 (BTA), with HCG NCHRI Oncology LLP, a wholly owned subsidiary, for the acquisition of the oncology business of HCG NCHRI Oncology LLP, located at Nagpur, on a slump sale basis. The consideration payable to the Company by the Seller shall not exceed Rs 25 crore, which shall be determined on the effective date of transfer.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises to discuss results
Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 9 November 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Healthcare Global Enterprises to convene AGM
Healthcare Global Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Healthcare Global Enterprises consolidated net profit rises 58.74% in the June 2024 quarter
Net profit of Healthcare Global Enterprises rose 58.74% to Rs 12.08 crore in the quarter ended June 2024 as against Rs 7.61 crore during the previous quarter ended June 2023. Sales rose 14.14% to Rs 524.69 crore in the quarter ended June 2024 as against Rs 459.71 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales524.69459.71 14 OPM %17.3216.16 - PBDT66.0051.53 28 PBT18.9910.52 81 NP12.087.61 59 Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 14.41%, vs industry avg of 10.01%
Over the last 5 years, market share increased from 2.69% to 3.04%